These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16475679)

  • 21. Vimentin methylation as a marker for advanced colorectal carcinoma.
    Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
    Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
    Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of multiple genes in gastric carcinomas.
    Zhao YF; Zhang YG; Tian XX; Juan Du ; Jie Zheng
    Int J Surg Pathol; 2007 Jul; 15(3):242-51. PubMed ID: 17652530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
    Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
    Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
    Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
    Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Goto T; Mizukami H; Kitamura YH; Sakuraba K; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jun; 29(6):2215-7. PubMed ID: 19528483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer.
    Wiencke JK; Zheng S; Lafuente A; Lafuente MJ; Grudzen C; Wrensch MR; Miike R; Ballesta A; Trias M
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):501-6. PubMed ID: 10385139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
    Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
    J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas.
    Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N
    Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.